ORMP · Oramed Pharmaceuticals Inc.
AI read · Neutral
The AI's read
The company said it changed its bylaws to avoid the distraction and cost of more litigation. It denied that the old rules broke the law and paid the legal fees without admitting fault. The case is closed, and the filing does not describe a change to Oramed's business outlook.